
ErythromycinroxithromycinImpuritiesPharmaceutical Reference StandardsIntermediates and building blocks
ErythromycinCAS 114-07-8
- Catalogue No.
- CSL-3391
- Alternative Cat. No.
- E649950
- CAS No.
- 114-07-8
- Molecular formula
- C37H67NO13
- Molecular weight
- 733.93
- Parent drug
- Erythromycin, roxithromycin
- Product type
- Impurities, Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals, Agro-chemical Standards, USP standards, EP standards
Quick quote · CSL-3391Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- E-Base
- E-Mycin
- Erytromycin A
Show all 15 synonyms
- Aknemycin
- Aknin
- emgel
- Ery-Derm
- Erymax
- Ery-Tab
- Erythromid
- ERYC
- Erythromycin A
- (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-d-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione (USP)
- Roxithromycin - Impurity A
- Erythromycin for impurity M identification (Y0001846)
More Erythromycin products
All 152 →![Chemical structure of (1R,2R,3R,6R,7S,8S,9R,10R,12S,17R)-9-((4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3-ethyl-2,10-dihydroxy-7-((5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-15-azabicyclo[12.2.1]heptadec-14-en-5-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2R3R6R7S8S9R10R12S17R-9-4-Dimethylamino-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy-3-ethyl-210-dihydroxy-7-5-hydroxy-4-methoxy-46-dimethyltetrahy.png&w=3840&q=75)
(1R,2R,3R,6R,7S,8S,9R,10R,12S,17R)-9-((4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3-ethyl-2,10-dihydroxy-7-((5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-15-azabicyclo[12.2.1]heptadec-14-en-5-oneCSL-199079

(2R,3R,6R,8R,9R,10S,11S,12R)-2-((2R,3R)-2,3-Dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-hydroxy-11-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one200420-00-4

(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-11-(((2S,3S,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-1-oxa-7-azacyclopentadecan-15-oneCSL-199431
![Chemical structure of (2S,4R,4a'R,5S,6S,7'R,8'S,9'R,10'S,12'R,14'R,15'R,16'S,16a'S,E)-15'-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7'-ethyl-5,8',9',14'-tetrahydroxy-11'-(hydroxyimino)-4-methoxy-4,6,8',10',12',14',16'-heptamethylhexadecahydro-4'H,5'H-spiro[pyran-2,2'-[1,3]dioxino[5,4-c][1]oxacyclotetradecin]-5'-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S4R4aR5S6S7R8S9R10S12R14R15R16S16aSE-15-2S3R4S6R-4-Dimethylamino-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy-7-ethyl-58914-tetrahydroxy-11-hydroxyi.png&w=3840&q=75)
(2S,4R,4a'R,5S,6S,7'R,8'S,9'R,10'S,12'R,14'R,15'R,16'S,16a'S,E)-15'-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7'-ethyl-5,8',9',14'-tetrahydroxy-11'-(hydroxyimino)-4-methoxy-4,6,8',10',12',14',16'-heptamethylhexadecahydro-4'H,5'H-spiro[pyran-2,2'-[1,3]dioxino[5,4-c][1]oxacyclotetradecin]-5'-oneCSL-199395

